Japan will be sending the anti-flu drug Avigan to the Philippines free of charge for Coronavirus Disease 2019 (COVID-19) clinical studies. The drug will also be sent to 43 recipient countries, confirms Foreign Minister Toshimitsu Motegi. The drug is expected to be sent after the Golden Week Holiday through May 06.
“We will cooperate with the private sector as well as the international community to develop a treatment” states Foreign Minister Toshimitsu Motegi. By far, several countries have shown interest in the drug.
Japan has also shown interest in the drug and has been conducting clinical studies after Chinese scientists revealed that it had been effective in treating COVID-19 patients. Moreover, Japan will be paying for the initiative through a $1 million grant to the United Nations Office for Project Services. Read more: Japan to send anti-flu drug Avigan to the Philippines, an article by ABS CBN News.
Avigan (Favipiravir) is an anti-viral medication (a pyrazine carboxamide derivative) used to treat influenza and is also being studied to treat other viral infections as well. It is being developed and manufactured by Toyama Chemical (Fujifilm Group) and approved for use in Japan in 2014.